Oncol­o­gy 2024

PORT for Health – con­fer­ence series

Wel­come to the PORT for Health: Oncol­o­gy 2024 con­fer­ence, where we con­verge to explore the lat­est break­throughs in three piv­otal oncol­o­gy-relat­ed domains: can­cer biol­o­gy, can­cer ther­a­py, and can­cer neu­ro­science. As an ini­tia­tive of Łukasiewicz – PORT, our pri­ma­ry mis­sion focus­es on advanc­ing new ther­a­peu­tic avenues for onco­log­i­cal dis­eases. This con­fer­ence serves as a bea­con for col­lab­o­ra­tion, offer­ing a plat­form for sci­en­tists, clin­i­cians, and indus­try lead­ers to engage in dynam­ic dis­course, exchange knowl­edge, and cat­alyze trans­for­ma­tive projects. Amidst the back­drop of cut­ting-edge research, par­tic­i­pants will have the oppor­tu­ni­ty to lis­ten to over 20 lec­tures pre­sent­ing the lat­est research find­ings in the intri­cate bio­log­i­cal under­pin­nings of can­cer devel­op­ment, explore the fron­tier of pre­ci­sion ther­a­pies, and unrav­el the intri­cate rela­tion­ship between can­cer and the ner­vous sys­tem. Through shared insights and best prac­tices, the PORT for Health: Oncol­o­gy 2024 endeav­ors to pro­pel oncol­o­gy research for­ward, ush­er­ing in a new era of inno­va­tion in the fight against cancer.

PORT for Health: Neuroscience 2023 conference at Łukasiewicz – PORT
PORT FOR HEALTH Neurosciece is organized by the Life Sciences and Biotechnology Center (LSnBC) located at the Łukasiewicz – PORT

PORT for Health: Oncol­o­gy 2024 conference

PORT FOR HEALTH: Oncol­o­gy 2024 is orga­nized by the Life Sci­ences and Biotech­nol­o­gy Cen­ter (LSnBC) locat­ed at the Łukasiewicz – PORT Pol­ish Cen­ter for Tech­nol­o­gy Devel­op­ment in Wro­claw, a part of the Łukasiewicz Research Net­work. The mis­sion of the dynam­i­cal­ly grow­ing LSnBC is to tack­le the biggest chal­lenges of mod­ern med­i­cine through top-notch research accom­plished by teams led by cre­ative and expe­ri­enced lead­ers. The LSnBC focus­es on a vari­ety of research top­ics, includ­ing trans­la­tion­al research uti­liz­ing mol­e­c­u­lar and com­pu­ta­tion­al pathol­o­gy to under­stand tumor microen­vi­ron­ment, DNA repair mech­a­nisms and the evo­lu­tion of genome struc­ture in can­cer, immunomod­u­la­tion of can­cer growth by innate-like immune cells (ILCs and γδ T lym­pho­cytes) and neu­ro­genic reg­u­la­tion of car­cino­gen­e­sis and asso­ci­at­ed sen­so­ry changes, par­tic­u­lar­ly pain and pares­the­sia. These diverse research areas col­lec­tive­ly aim to uncov­er mech­a­nisms of tumor devel­op­ment, iden­ti­fy diag­nos­tic and prog­nos­tic bio­mark­ers, and devel­op inno­v­a­tive anti-can­cer drugs and immunotherapies.